ContraVir Pharmaceuticals Inc. Daily Stock Analysis

Daily Stock Analysis, CTRV, ContraVir Pharmaceuticals Inc, priceseries

ContraVir Pharmaceuticals Inc. Daily Stock Analysis
Stock Information
Open
3.03
Close
2.93
High
3.15
Low
2.80
Previous Close
3.03
Daily Price Gain
-0.10
YTD High
3516.80
YTD High Date
Oct 5, 2015
YTD Low
2.69
YTD Low Date
Jul 24, 2019
YTD Price Change
-417.07
YTD Gain
-99.30%
52 Week High
3516.80
52 Week High Date
Oct 5, 2015
52 Week Low
2.69
52 Week Low Date
Jul 24, 2019
52 Week Price Change
-417.07
52 Week Gain
-99.30%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Feb 7. 2017
800.80
Feb 21. 2017
863.55
9 Trading Days
7.84%
Link
LONG
Apr 19. 2017
901.60
Apr 20. 2017
968.80
1 Trading Days
7.45%
Link
LONG
Aug 17. 2017
330.40
Aug 21. 2017
347.20
2 Trading Days
5.08%
Link
LONG
Oct 2. 2017
296.80
Oct 6. 2017
327.60
4 Trading Days
10.38%
Link
LONG
Oct 12. 2017
395.42
Oct 13. 2017
415.77
1 Trading Days
5.15%
Link
LONG
Oct 18. 2018
38.49
Oct 19. 2018
41.30
1 Trading Days
7.28%
Link
LONG
Jan 10. 2019
25.41
Jan 11. 2019
27.58
1 Trading Days
8.54%
Link
LONG
Mar 11. 2019
16.99
Mar 14. 2019
17.89
3 Trading Days
5.29%
Link
Company Information
Stock Symbol
CTRV
Exchange
NasdaqCM
Company URL
http://www.contravir.com
Company Phone
732-902-4000
CEO
James E. Sapirstein
Headquarters
New Jersey
Business Address
399 THORNALL STREET, FIRST FLOOR, EDISON, NJ 08837
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001583771
About

ContraVir Pharmaceuticals, Inc. is a development stage biopharmaceutical company which is focused primarily on the development of drugs to treat herpes zoster or shingles. The company currently developing a compound called FV-100 for the treatment of shingles. It is also developing CMX157, a potent analog of the successful antiviral drug tenofovir DF. ContraVir Pharmaceuticals was founded on May 15, 2013 and is headquartered in Edison, NJ.

Description

ContraVir Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development of antiviral drugs with a primary emphasis on the treatment of Hepatitis B virus (HBV) infections. The company is developing CMX157 and CRV431 to treat HBV infection; and FV-100, an orally available, small molecule compound for the prevention of post-herpetic neuralgia, and treatment of herpes zoster infection and acute zoster-associated pain. ContraVir Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Edison, New Jersey.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading